Commons Sense

House of Commons · Written Ministerial Statement

Health Update

28 March 2022 · Department of Health and Social Care

Proposed by Maggie Throup Con Erewash

NHS

Summarised by AI from the official record, so it can contain mistakes.

View on Parliament.uk

At a glance

Key points

  • UK consolidates Therapeutics and Antivirals Taskforces into a single entity to continue overseeing antiviral and therapeutic interventions for COVID-19.
  • NICE will conduct a Multiple Technology Appraisal of COVID-19 therapeutics in the long term.
  • The statement highlights the UK's success in deploying COVID-19 treatments through the Therapeutics Taskforce.

Issue summary

The statement discusses the UK's successful deployment of treatments for COVID-19 through the Therapeutics Taskforce and the recent achievements of the Antivirals Taskforce.

Action requested

The minister announces the consolidation of the Therapeutics and Antivirals Taskforces into a single taskforce, which will continue to oversee the delivery of antiviral and therapeutic interventions for those in need. Longer term, NICE will conduct a Multiple Technology Appraisal of COVID-19 therapeutics.

Key facts

  • In April 2020, there were no proven effective treatments for COVID-19.
  • The Therapeutics Taskforce identified and made available dexamethasone, reducing mortality risk by up to 35%.
  • The Antivirals Taskforce secured almost five million patient courses of oral antivirals.
  • Eddie Gray led the Antivirals Taskforce.
  • NICE will conduct a Multiple Technology Appraisal of COVID-19 therapeutics.
▸ Assessment & feedback
Summary accuracy